Hangzhou Jiuge Biotech’s innovative membrane protein production technology creates collaboration opportunities for the European pharmaceutical industry. (Source: Hangzhou Jiuge Biotech) Amid rising R&D costs and increasing...
Rising uncertainty driven by US tariffs and proposed “most-favoured nation” pricing is prompting pharmaceutical companies to delay investment and product launches in Europe. US tariffs and...
As a first step towards the adoption of a Pharmaceutical Strategy for Europe the Commission has published a road map, inviting interested citizens and stakeholders to...
New medicine prices in the EU have risen over the past few decades, to the point of being unaffordable for many EU citizens and threatening the...
By European Alliance for Personalised Medicine (EAPM) Executive Director Denis Horgan This week saw the launch of the European Commission’s Digital Single Market Strategy, which can...
Today (10 September) the Commission adopted proposals on veterinary medicines and medicated feed, which aim to improve animal health and public health, as well as the internal...
Today (10 September), the Commission adopted proposals on veterinary medicinal products and medicated feed, to improve the health and wellbeing of animals, to tackle antimicrobial resistance...
